Ceballos ÁA, Luis GA, Fuentes HL, Lastayo CRG, Torres CR, Gutiérrez DMJ, Moré DA

Language: English
References: 15
Page: 123-129
PDF size: 523.61 Kb.

ABSTRACT

Introduction: Fever is one of the difficulties that appear in the postoperative period.
Objective: To characterize the incidence of postoperative fever in cardiovascular surgery.
Method: Observational, descriptive, longitudinal, prospective study in 31 patients with fever in the postoperative period.
Results: Of all patients undergoing cardiovascular surgery, 15.6% (31 cases) had postoperative fever; and it had a septic cause in 20 of them. It appeared more frequently in males (74.2%), after two-valve surgery or coronary artery bypass grafting (67.7%) and in the 30-49 years age group (48.9%). Pleural (29.0%) and pericardial effusion (19.4%), and pulmonary inflammatory lesions (25.8%) were more commonly found; most patients had 2 central venous catheters (77.4%) and had been with bladder catheter (51.6%) or arterial line (48.4%) for more than three days. Metamizol was administered to 87.1% of patients, 58.1% received antimicrobial drugs and a sample for blood culture was taken in 25.8% of them. Pseudomonas and Acinetobacter were the germs most commonly found, and the outcome was satisfactory in most cases (only 1 patient died).
Conclusions: The frequency of postoperative fever in cardiovascular surgery was not high. There was a predominance of male patients, in the 30-49 years age group, with complex surgery. Pleural and pericardial effusions were more commonly found, as well as the use of multiple invasive procedures. Blood culture was useful in determining the cause of fever, and the type of germ. Most patients had a satisfactory out-come.

REFERENCES

1. Fariñas MC. Enfermedades Infecciosas. Fiebre en el postoperatorio. [Artículo en internet]. Universidad de Cataluña [citado 22 Ago 2014]. Disponible en: http://ocw.unican.es/ciencias-de-la-salud/enfermedades-infecciosas/materiales-de-clase-1/Tema%2029.pdf

2. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emo-ri TG. CDC definitions of nosocomial surgical site infections, 1992: A modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13:606-8.

3. Villasís-Keever MA, Zapata-Arenas DM, Penagos-Paniagua MJ. Frecuencia y factores de riesgo aso-ciados con el desarrollo de fiebre postoperatoria en niños con cardiopatía congénita sometidos a cirugía cardiovascular. Rev Esp Cardiol. 2002;55:1063-9.

4. Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J,Block PC, et al. Unexplained in-hospital fever following cardiac surgery. Natural history, relationship to postpericardiotomy syndrome, and a prospective study of therapy with indomethacin versus placebo. Circulation. 1978;57:968-75.

5. Lee JT. Surgical infection nomenclature. World J Surg. 2006;30:478.

6. Lifshitz A. Fiebre y otras formas de elevación tér-mica. Rev Invest Clin. 2007;59:130-8.

7. Vera P, Zapata L, Gich I, Mancebo J, Betbesé AJ. Efectos hemodinámicos y antipiréticos del parace-tamol, metamizol y dexketoprofeno en pacientes críticos. Med Intensiva. 2012;36:619-25.

8. Arnáiz E. Manejo en urgencias del paciente some-tido a cirugía cardiaca. [Artículo en internet]. Sala-manca 2013 [citado 22 Ago 2014]. Disponible en: http://www.fucalec.com/socalec/CONGRESOS/XVIII_Salamanca_2013/Documentos_trabajos/Manejo_en_urgencias.pdf

9. Periáñez L, Álvarez L, Barceló C, Rodríguez R, Bar-celó B. Farmacocinética/Farmacodinamia en anti-bioterapia. En: Martín ML, Murillas J, eds. Guías de tratamiento empírico de las enfermedades infec-ciosas. 2ª Ed. Palma de Mallorca: Hospital Universi-tari Son Espases. Comisión de Infección Hospitala-ria, Profilaxis y Política antibiótica; 2012. p. 26-9.

10. 10.Lola I, Levidiotou S, Petrou A, Arnaoutoglou H, Apostolakis E, Papadopoulos GS. Are there inde-pendent predisposing factors for postoperative in-fections following open heart surgery? J Cardio-thorac Surg [Internet]. 2011 [citado 27 Dic 2014];6: 151[aprox. 9 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223138/pdf/1749-8090-6-151.pdf

11. 11.Rodríguez-Baño J, Paño-Pardo JR, Álvarez-Rocha L, Asensio Á, Calbo E, Cercenado E, et al. Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH. Farm Hosp. 2012; 36(1):33.e1-e30.

12. 12.Deniz H, Gokaslan G, Arslanoglu Y, Ozcaliskan O, Guzel G, Yasim A, et al. Treatment outcomes of postoperative mediastinitis in cardiac surgery; neg-ative pressure wound therapy versus conventional treatment. J Cardiothorac Surg [Internet]. 2012 [ci-tado 6 Ene 2015];7:67[aprox. 7 p.]. Disponible en: http://www.cardiothoracicsurgery.org/content/pdf/1749-8090-7-67.pdf

13. 13.Snefjellå N, Lappegård KT. Development of post-pericardiotomy syndrome is preceded by an in-crease in pro-inflammatory and a decrease in anti-inflammatory serological markers. J Cardiothorac Surg [Internet]. 2012 [citado 6 Ene 2015];7: 72[aprox. 3 p.]. Disponible en: http://www.cardiothoracicsurgery.org/content/pdf/1749-8090-7-72.pdf

14. 14.Soto S, Quirós P, Chamorro R, Garita E, Robelo B, Salazar C. Infección de esternotomía media des-pués de cirugía cardiovascular. Experiencia en el Hospital R.A. Calderón Guardia. Rev Costarric Car-diol. 2010;12:11-6.

15. 15.Alraies MC, Al Jaroudi W, Shabrang C, Yarmoham-madi H, Klein AL, Tamarappoo BK. Clinical features associated with adverse events in patients with post-pericardiotomy syndrome following cardiac surgery. Am J Cardiol. 2014;114:1426-30.